LMAT vs T · P/E 35, rev $136.9M vs P/E 7.4, rev $125.65B
LeMaitre Vascular Inc (LMAT) versus AT&T Inc. (T) — a side-by-side from cached financials, not a winner call.
LeMaitre Vascular Inc (LMAT) is a medical instruments & supplies company listed on US.
AT&T Inc. (T) is a telecom services company listed on NYSE. It is led by John Stankey.
Latest reported LMAT revenue for 2026-06-30 was $136.9M. Net income was $32.7M. LMAT currently screens at market cap $2.16B and trailing P/E 34.8.
Latest reported T revenue for 2025-12-31 was $125.65B. Net income was $21.95B. Revenue was up 2.7% from 2024-12-31 to 2025-12-31. T currently screens at market cap $155.92B and trailing P/E 7.4.
LMAT currently screens at market cap $2.16B and trailing P/E 34.8. T currently screens at market cap $155.92B and trailing P/E 7.4.
Not investment advice. Open the LMAT and T stock pages for the full models.
Not investment advice.